Navigation Links
Lanx, Inc. Appoints Dan Gladney Chief Executive Officer
Date:12/15/2010

BROOMFIELD, Colo., Dec. 15, 2010 /PRNewswire/ -- Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, announced the appointment of Dan W. Gladney as Chief Executive Officer and as a member of the Board of Directors. He will assume the role on January 10, 2011. Gladney has more than 25 years of experience in the medical device industry, founding and leading companies in the orthopedic and cardiology sectors.

Dr. Jeffrey Thramann, Co-founder and Chairman, said, "The Board and the Lanx executive team are pleased to welcome Dan into this leadership position. His specific operating experience as Chief Executive of several emerging medical technology companies and public company experience makes him an ideal fit for our organization. We are confident he will make major contributions to the next stage of our growth and expansion."

Dan Gladney said, "I am excited to be joining the exceptional team here at Lanx as the company develops into a world-class spine company.  The Company's dedication to surgeon driven innovation, impressive product portfolio, deep pipeline, and talented employees will continue to serve as a strong platform for growth and success. I look forward to working with the expanded team to bring innovative solutions to surgeons and patients."

Gladney was most recently Healthcare Operating Partner at Norwest Equity Partners (NEP) where he was responsible for strategic planning, business growth and corporate governance for NEP portfolio companies and evaluating and executing new investment opportunities for the firm.

Prior to joining NEP, Gladney served as President and CEO of several successful medical device companies, including DGIMED Ortho, Heart Leaflet Technologies and ACIST Medical Systems. He also served as Chairman, CEO and President of Compex Technologies, a publicly traded orthopedic and health and wellness electro therapy company. 

Gladney was named in Twin Cities Business Journal's "Top 40 CEO's to Watch" in 2004 and featured on the cover of "Upsize Business Magazine" in 2005 for his noteworthy, collaborative leadership style. He holds a BA from Eastern Michigan University. 

About Lanx, Inc.Lanx is one of the largest and fastest growing privately held global spine companies. The Company was founded by a team of experienced medical device professionals and engineers in 2003 to improve the quality of spine care and provide surgeons with innovative products. Lanx develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. The Company is headquartered in Broomfield, CO. More information on Lanx and its spinal surgery products can be found at www.lanx.com. Company Investor Contact:Steve DeitschChief Financial Officer(303) 443-7500steve.deitsch@lanx.comThe Ruth GroupMedia / Investors:Kimberly Muscara / Nick Laudico(973) 768-0449 / (646) 536-7030kmuscara@theruthgroup.comnlaudico@theruthgroup.com
'/>"/>

SOURCE Lanx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Curemark Appoints Jennifer Katritos, CPA as Vice President of Finance
2. Advanced BioHealing Appoints Kevin C. OBoyle as Chief Financial Officer
3. Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer
4. Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer
5. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
6. CSA Medical Appoints William H. Floyd President and CEO
7. Breathe Technologies Appoints New CEO
8. Vanda Pharmaceuticals Appoints Chief Financial Officer
9. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
10. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
11. Hill-Rom Appoints Mark Guinan as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease Control ... of October . PhysicianOne Urgent Care is helping communities across ... NY , by offering no-cost* flu shots through the end of ... by certain health insurance regulations. ... best time to get a flu shot is by the end of ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):